Blog

Takeda Pharmaceutical Company, the maker of popular diabetes drug Actos, has offered $2.2 billion to settle claims of bladder cancer developing after taking Actos.

Takeda Pharmaceutical Company, the maker of popular diabetes drug Actos, has offered $2.2 billion to settle over 8,000 claims of bladder cancer developing after taking Actos. Actos sales have been estimated at more than $16 billion since 1999. The offer of about $275,000 per case is significantly below what plaintiffs have received in jury verdicts against the company, including one federal jury’s verdict of $9 billion (later reduced to $36.8 million).

Studies have shown that patients who take Actos for more than 12 months have a 40% increased risk of developing bladder cancer. One study showed that the risk of bladder cancer continues to increase the longer Actos is taken. Symptoms of bladder cancer include pain while urinating, red-colored urine, urgent needs to urinate, or pain in the back or lower abdomen.

See the news story here.

The Law Offices of Larry H. Parker has been working with a nationally recognized team of attorneys to represent the victims of Actos in litigation against Takeda. If you or a loved one has developed bladder cancer after taking Actos, contact us today at (800) 333-0000 for a free consultation. You may be entitled to compensation.